Page last updated: 2024-08-26

cv 3988 and web 2086

cv 3988 has been researched along with web 2086 in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.14)18.7374
1990's11 (78.57)18.2507
2000's1 (7.14)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bates, EJ; Ferrante, A; Kowanko, IC1
Chang, SW; Chen, CR; Voelkel, NF1
Bates, EJ; Ferrante, A; Harvey, DP1
McIntyre, TM; Prescott, SM; Smiley, PL; Stremler, KE; Zimmerman, GA1
Imura, Y; Kawamura, M; Nishikawa, K; Takatani, M; Terashita, Z; Tsushima, S1
Franklin, R; Gelfand, EW; Mazer, BD; Sawami, H1
Terasawa, M1
Finn, CA; Milligan, SR1
Dixon, EJ; Page, CP; Robertson, DN; Wilsoncroft, P1
Evans, RJ; Jarvis, GE1
Bazan, HE; Tao, Y1
Akiyama, M; Ino, M; Miwa, M; Shimura, M; Sugatani, J; Suzuki, M; Suzuki, Y; Yamazaki, R1
Chen, R; Chen, X; McIntyre, TM; Salomon, RG1
Davoine, F; Druey, KM; Dyer, KD; Kim, JD; Lacy, P; Moqbel, R; Percopo, CM; Rosenberg, HF; Xie, Z; Yang, Z1

Other Studies

14 other study(ies) available for cv 3988 and web 2086

ArticleYear
Platelet-activating factor inhibits proteoglycan synthesis and enhances neutrophil-mediated proteoglycan degradation in cartilage explants.
    Arthritis and rheumatism, 1992, Volume: 35, Issue:8

    Topics: Animals; Azepines; Cartilage, Articular; Cattle; Cells, Cultured; Granulocyte-Macrophage Colony-Stimulating Factor; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Proteoglycans; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sulfur Radioisotopes; Triazoles; Tumor Necrosis Factor-alpha

1992
Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
    Journal of applied physiology (Bethesda, Md. : 1985), 1992, Volume: 73, Issue:5

    Topics: Angiotensin II; Animals; Azepines; Hypoxia; In Vitro Techniques; Male; Phospholipid Ethers; Platelet Activating Factor; Pulmonary Circulation; Pulmonary Edema; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Triazoles; Vasoconstriction; Vasodilation

1992
Inhibition of neutrophil respiratory burst and degranulation responses to platelet-activating factor by antagonists WEB 2086, CV 6209 and CV 3988.
    International archives of allergy and immunology, 1992, Volume: 97, Issue:1

    Topics: Azepines; Cell Degranulation; Cell Survival; Humans; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Pyridinium Compounds; Respiratory Burst; Triazoles

1992
Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
    The Journal of biological chemistry, 1991, Jun-15, Volume: 266, Issue:17

    Topics: Azepines; Cell Adhesion; Furans; Humans; Hydrolysis; In Vitro Techniques; Indicators and Reagents; Kinetics; Neutrophils; Oxidation-Reduction; Phosphatidylcholines; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles

1991
Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:2

    Topics: Anaphylaxis; Animals; Azepines; Furans; Hemolysis; Humans; Hypotension; Isoquinolines; Male; Microsomes; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rabbits; Rats; Rats, Inbred Strains; Shock, Septic; Tetrahydroisoquinolines; Triazoles

1992
B-cell activation and regulation of immunoglobulin synthesis by platelet activating factor.
    The Netherlands journal of medicine, 1991, Volume: 39, Issue:3-4

    Topics: Azepines; B-Lymphocytes; Calcium; Cell Differentiation; Cell Line; Inositol; Lymphocyte Activation; Phospholipid Ethers; Platelet Activating Factor; Receptors, Antigen, B-Cell; Triazoles

1991
[Platelet-activating factor (PAF) antagonists].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1991, Volume: 36, Issue:3

    Topics: Animals; Azepines; Binding, Competitive; Diterpenes; Furans; Ginkgolides; Humans; Lactones; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles

1991
Failure of platelet-activating factor (PAF-acether) to induce decidualization in mice and failure of antagonists of PAF to inhibit implantation.
    Journal of reproduction and fertility, 1990, Volume: 88, Issue:1

    Topics: Animals; Azepines; Decidua; Diterpenes; Embryo Implantation; Estradiol; Female; Ginkgolides; Lactones; Mice; Mice, Inbred Strains; Ovariectomy; Phospholipid Ethers; Platelet Activating Factor; Pregnancy; Progesterone; Triazines; Triazoles

1990
The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin.
    British journal of pharmacology, 1989, Volume: 97, Issue:3

    Topics: Acetylcholine; Animals; Azepines; Bronchi; Diterpenes; Ginkgolides; Guinea Pigs; Histamine; In Vitro Techniques; Indomethacin; Lactones; Male; Phospholipid Ethers; Platelet Activating Factor; Propranolol; Respiratory Hypersensitivity; Triazines; Triazoles

1989
Platelet-activating factor and not thromboxane A2 is an important mediator of endotoxin-induced platelet aggregation in equine heparinised whole blood in vitro.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1996, Volume: 7, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azepines; Carbazoles; Clonixin; Endotoxins; Heparin; Horses; In Vitro Techniques; Phospholipases A; Phospholipases A2; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinacrine; Thromboxane A2; Triazoles

1996
PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1997, Volume: 13, Issue:3

    Topics: Azepines; Cornea; Corneal Injuries; Diterpenes; Enzyme Activation; Epithelium; Extracellular Matrix Proteins; Fibrinolytic Agents; Ginkgolides; Lactones; Metalloendopeptidases; Phospholipid Ethers; Platelet Activating Factor; Thienopyridines; Triazoles; Urokinase-Type Plasminogen Activator; Wound Healing

1997
Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    The American journal of physiology, 1998, Volume: 274, Issue:1

    Topics: Animals; Azepines; Blood Platelets; Humans; In Vitro Techniques; Kinetics; Neutrophils; P-Selectin; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Thiazolidines; Triazoles

1998
Platelet activation by low concentrations of intact oxidized LDL particles involves the PAF receptor.
    Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:3

    Topics: Adenosine Diphosphate; Azepines; Blood Platelets; Calcium Signaling; Collagen; Humans; Ligands; Lipoproteins, LDL; Membrane Potential, Mitochondrial; Mitochondria; P-Selectin; Phospholipid Ethers; Phospholipids; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Thrombin; Time Factors; Triazoles

2009
Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor.
    Journal of immunology (Baltimore, Md. : 1950), 2010, Jun-01, Volume: 184, Issue:11

    Topics: Animals; Azepines; Cell Degranulation; Eosinophils; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Triazoles

2010